Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Array Biopharma Inc (NASDAQ:ARRY)

3.17
Delayed Data
As of 3:59pm ET
 -0.06 / -1.86%
Today’s Change
2.38
Today|||52-Week Range
6.04
-24.88%
Year-to-Date
Why Array BioPharma Inc. Is Plunging Today
Aug 09 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.23
Today’s open3.25
Day’s range3.10 - 3.32
Volume1,222,060
Average volume (3 months)1,978,766
Market cap$468.4M
Dividend yield--
Data as of 3:59pm ET, 08/25/2016

Growth & Valuation

Earnings growth (last year)-1,028.57%
Earnings growth (this year)-4.04%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+165.62%
P/E ratioNM
Price/Sales3.69
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CYTKCytokinetics Inc+0.20+1.68%
FLXNFlexion Therapeutics...-0.06-0.36%
OMEROmeros Corp0.000.00%
PGNXProgenics Pharmaceut...-0.04-0.61%
Data as of 4:00pm ET, 08/25/2016

Financials

Next reporting dateOctober 31, 2016
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$137.9M
Annual profit (last year)-$92.8M
Net profit margin-67.33%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Ron Squarer
Chief Operating Officer
Andrew R. Robbins
Corporate headquarters
Boulder, Colorado

Forecasts

Partner Offers

Search for Jobs